BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Business

  Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates

  Gritstone bio, Inc., a clinical-stage biotechnology company working to develop the world’s most potent vaccines, reported financial results for the first quarter ended March 31, 2024 and provided recent corporate and clinical updates.

  May 9, 2024

   · 

  12 min read
• Business

  Kronos Bio Reports First-Quarter 2024 Financial Results

  Kronos Bio, Inc. reported recent business progress and financial results for the first-quarter of 2024.

  May 9, 2024

   · 

  7 min read
• Biotech Bay

  Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference 2024

  Amgen will present at the Bank of America Merrill Lynch Global Healthcare Conference at 9:20 a.m. PT on Tuesday, May 14, 2024.

  May 9, 2024

   · 

  2 min read
• Business

  Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results

  Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced financial results for the quarter ended March 31, 2024.

  May 9, 2024

   · 

  10 min read
• Business

  Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

  Oncolytics Biotech® Inc., a leading clinical-stage company specializing in immunotherapy for oncology, announced recent operational highlights and financial results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  15 min read
• Business

  Ginkgo Bioworks Reports First Quarter 2024 Financial Results

  Ginkgo Bioworks Holdings, Inc., which is building the leading platform for cell programming and biosecurity, announced its results for the first quarter ended March 31, 2024.

  May 9, 2024

   · 

  19 min read
• Business

  Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

  Spyre Therapeutics, Inc. announced its first quarter 2024 financial results and provided program and corporate updates.

  May 9, 2024

   · 

  14 min read
• Business

  BioLife Solutions Reports First Quarter 2024 Financial Results

  BioLife Solutions, Inc. announced financial results for the three months ended March 31, 2024 and affirmed its revenue guidance for 2024.

  May 9, 2024

   · 

  17 min read
• Business

  Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights

  Tyra Biosciences, Inc. reported financial results for the quarter ended March 31, 2024, and highlighted recent corporate progress.

  May 9, 2024

   · 

  11 min read
• Business

  Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights

  Avidity Biosciences, Inc. reported financial results for the first quarter ended March 31, 2024, and highlighted recent corporate progress.

  May 9, 2024

   · 

  10 min read